Concepedia
Statistics
Publications
6
Citations
471
H-Index
Active since
2011
Affiliations
University of Oxford(Current)
CRUK/MRC Oxford Institute for Radiation Oncology
John Radcliffe Hospital
University of Copenhagen
Thomas M. Ashton is an author at University of Oxford specializing in medicine, oncology, and cancer pharmacology.
Publications per year
2011–2020
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
Thomas M. Ashton, Emmanouil Fokas, Leoni A. Kunz‐Schughart et al. · Nature Communications · 2016 · 253 citations · Full text
Medicine, Oncology, Pharmacology +14
Pathways for Holliday Junction Processing during Homologous Recombination in <i>Saccharomyces cerevisiae</i>
Thomas M. Ashton, Hocine W Mankouri, A Heidenblut et al. · Molecular and Cellular Biology · 2011 · 62 citations · Full text
Life Sciences, Genetics, Molecular Biology +16
Holliday junction-containing DNA structures persist in cells lacking Sgs1 or Top3 following exposure to DNA damage
Hocine W Mankouri, Thomas M. Ashton, Ian D. Hickson · Proceedings of the National Academy of Sciences · 2011 · 56 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia
Kamila Hussien, Emmanouil Fokas, Pavitra Kannan et al. · Radiotherapy and Oncology · 2014 · 50 citations · Full text
Medicine, Cancer Biology, Oncology +17
TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy
Giacomo Pirovano, Thomas M. Ashton, Katharine Herbert et al. · British Journal of Cancer · 2017 · 26 citations · Full text
Medicine, Oncology, Radiation Oncology +17
1–5 of 6